\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ patient\\ is\\ currently\\ being\\ followed\\ by\\ rheumatology\\.\ \(0\)\
\-\ foot\\:\\ osteoarthritis\\ of\\ the\\ first\\ mtp\\ is\\ demonstrated\\.\\ \\ there\\ is\\ ossification\\ of\\ the\\ achilles\\ tendon\\.\ \(0\)\
\-\ wrist\\:\\ calcification\\ of\\ the\\ tfcc\\ and\\ chondral\\ cartilage\\ of\\ the\\ wrist\\.\ \(0\)\
\-\ knee\\:\\ \\ chondrocalcinosis\\ is\\ present\\.\ \(0\)\
\-\ calcium\\ pyrophosphate\\ dihydrate\\ \\(cppd\\)\\ crystal\\ deposition\\ disease\ \(0\)\
\-\ gout\ \(75\)\
\-\ primary\\ hyperparathyroidism\ \(7\)\
\-\ hemochromatosis\ \(13\)\
\-\ knee\\ pain\\ in\\ an\\ elderly\\ male\\.\ \(0\)\
\-\ calcium\\ pyrophosphate\\ dihydrate\\ crystal\\ deposition\\ disease\\ is\\ characterized\\ by\\ calcification\\ in\\ and\\ around\\ joints\\ and\\ by\\ structural\\ changes\\ in\\ the\\ joints\\.\\ \\ this\\ is\\ pyrophosphate\\ arthropathy\\.\\ non\\-weight\\ bearing\\ joints\\ such\\ as\\ radiocarpal\\,\\ metacarpophalangeal\\ joints\\,\\ glenohumeral\\ joints\\ and\\ the\\ elbow\\ are\\ affected\\.\\ \\ patellofemoral\\ and\\ radiocarpal\\ joint\\ space\\ narrowing\\ may\\ be\\ seen\\.\\ \\ \ \(0\)\
\-\ subchondral\\ cysts\\ are\\ one\\ of\\ the\\ hallmarks\\ of\\ this\\ disease\\.\\ \\ cysts\\ may\\ form\\ before\\ cartilage\\ loss\\ presents\\.\\ \\ cysts\\ are\\ larger\\ and\\ more\\ numerous\\ that\\ in\\ osteoarthritis\\.\\ \\ \ \(0\)\
\-\ cppd\\ in\\ fibrocartilage\\ is\\ most\\ common\\ in\\ the\\ menisci\\ of\\ the\\ knee\\,\\ triangular\\ fibrocartilage\\ of\\ the\\ wrist\\,\\ acetabular\\ labrum\\,\\ pubic\\ symphysis\\ and\\ annulus\\ fibrosis\\ of\\ the\\ intervertebral\\ disk\\.\\ \\ \ \(0\)\
\-\ synovial\\ calcifications\\ are\\ common\\ in\\ the\\ wrist\\,\\ knee\\,\\ mcp\\ and\\ mtp\\ joints\\.\\ \\ capsular\\ calcification\\ is\\ most\\ commonly\\ observed\\ in\\ the\\ elbow\\,\\ glenohumeral\\,\\ mtp\\,\\ and\\ mcp\\ joints\\.\\ \\ \ \(0\)\
\-\ tendon\\ calcifications\\ are\\ present\\ in\\ as\\ much\\ as\\ 13\\%\\ of\\ patients\\.\\ \\ the\\ most\\ frequently\\ affected\\ sites\\ are\\ the\\ supraspinatus\\,\\ triceps\\,\\ quadriceps\\,\\ gastrocnemius\\ and\\ achilles\\ tendons\\.\ \(0\)\
\-\ the\\ lunotriquetral\\ ligament\\ is\\ more\\ common\\ than\\ the\\ triangular\\ fibrocartilage\\ to\\ be\\ calcified\\.\\ \\ degenerative\\ tears\\ of\\ the\\ triangular\\ fibrocartilage\\ and\\ degeneration\\ of\\ the\\ articular\\ cartilage\\ of\\ the\\ lunate\\ are\\ associated\\ with\\ cppd\\ crystal\\ deposits\\.\ \(0\)\
\-\ the\\ knee\\ is\\ most\\ commonly\\ involved\\ and\\ affects\\ the\\ medial\\ femortibial\\ compartment\\.\\ \\ isolated\\ patellofemoral\\ narrowing\\ should\\ suggest\\ underlying\\ cppd\\ crystal\\ deposition\\ disease\\ in\\ an\\ older\\ patient\\,\\ even\\ without\\ joint\\ calcification\\.\\ \\ wedge\\ shaped\\ meniscal\\ calcification\\ is\\ more\\ frequent\\ than\\ linear\\ calcification\\ \\(lateral\\ more\\ often\\ than\\ medial\\)\\.\ \(0\)\
\-\ the\\ talocalcaneonavicular\\ joint\\ may\\ be\\ selectively\\ affected\\ \\ the\\ achilles\\ tendon\\ and\\ plantar\\ fascia\\ may\\ calcify\\.\ \(0\)\
\-\ steinbach\\,\\ ls\\ \\"calcium\\ pyrophosphate\\ dihydrate\\ and\\ calcium\\ hydroxyapatite\\ crystal\\ deposition\\ diseases\\:\\ imaging\\ perspectives\\"\\.\\ \\ radiologic\\ clinics\\ of\\ north\\ america\\ 42\\ \\(2004\\)\\ 185\\-205\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ joints\\:\\ 0\\.2626632366298962\ \(0\)\
\-\ crystal\\:\\ 0\\.25732165459300727\ \(0\)\
\-\ fibrocartilage\\:\\ 0\\.21758166033335552\ \(0\)\
\-\ the\\:\\ 0\\.209063652822542\ \(0\)\
\-\ pyrophosphate\\:\\ 0\\.2044965456785218\ \(0\)\
\-\ cppd\\:\\ 0\\.19344503751740355\ \(0\)\
\-\ calcification\\:\\ 0\\.18701140544949185\ \(0\)\
\-\ deposition\\:\\ 0\\.17618158370082884\ \(0\)\
\-\ mtp\\:\\ 0\\.16830947575299027\ \(0\)\
\-\ dihydrate\\:\\ 0\\.16830947575299027\ \(0\)\
\-\ calcium\\:\\ 0\\.15772238760454768\ \(0\)\
\-\ knee\\:\\ 0\\.15646103517140117\ \(0\)\
\-\ wrist\\:\\ 0\\.15077611228037544\ \(0\)\
\-\ triangular\\:\\ 0\\.13508915894323914\ \(0\)\
\-\ is\\:\\ 0\\.13151089237063884\ \(0\)\
\-\ achilles\\:\\ 0\\.1278186311045283\ \(0\)\
\-\ and\\:\\ 0\\.12629415011314438\ \(0\)\
\-\ cartilage\\:\\ 0\\.12418591106827606\ \(0\)\
\-\ of\\:\\ 0\\.11960643846545892\ \(0\)\
\-\ are\\:\\ 0\\.11595868738967158\ \(0\)\
\-\ tendon\\:\\ 0\\.11432343237199863\ \(0\)\
\-\ radiocarpal\\:\\ 0\\.11098116490209306\ \(0\)\
\-\ in\\:\\ 0\\.10860235471496203\ \(0\)\
\-\ affected\\:\\ 0\\.10771843948708977\ \(0\)\
\-\ patellofemoral\\:\\ 0\\.10600017409015908\ \(0\)\
\-\ glenohumeral\\:\\ 0\\.1051726086490144\ \(0\)\
\-\ mcp\\:\\ 0\\.09979403101165797\ \(0\)\
\-\ cysts\\:\\ 0\\.09924420227666261\ \(0\)\
\-\ more\\:\\ 0\\.09588760198145158\ \(0\)\
\-\ most\\:\\ 0\\.09087994790895544\ \(0\)\
\-\ may\\:\\ 0\\.08787662258120385\ \(0\)\
\-\ joint\\:\\ 0\\.08630149948173141\ \(0\)\
\-\ elbow\\:\\ 0\\.08242176465983352\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.07975307123787542\ \(0\)\
\-\ common\\:\\ 0\\.07427412725924089\ \(0\)\
\-\ than\\:\\ 0\\.07424230556565922\ \(0\)\
\-\ disease\\:\\ 0\\.07330121816118577\ \(0\)\
\-\ femortibial\\:\\ 0\\.06981570179202098\ \(0\)\
\-\ steinbach\\:\\ 0\\.06981570179202098\ \(0\)\
\-\ perspectives\\:\\ 0\\.06981570179202098\ \(0\)\
\-\ narrowing\\:\\ 0\\.06768475982989944\ \(0\)\
\-\ talocalcaneonavicular\\:\\ 0\\.06671263025277044\ \(0\)\
\-\ commonly\\:\\ 0\\.06460692399405533\ \(0\)\
\-\ ls\\:\\ 0\\.06451096595780081\ \(0\)\
\-\ calcifications\\:\\ 0\\.06372256356320984\ \(0\)\
\-\ selectively\\:\\ 0\\.06280322245680961\ \(0\)\
\-\ hallmarks\\:\\ 0\\.06140789441855027\ \(0\)\
\-\ tfcc\\:\\ 0\\.05749848662258944\ \(0\)\
\-\ metacarpophalangeal\\:\\ 0\\.05749848662258944\ \(0\)\
\-\ medial\\:\\ 0\\.056833696618001237\ \(0\)\
\-\ lunotriquetral\\:\\ 0\\.05676906675282161\ \(0\)\
\-\ hydroxyapatite\\:\\ 0\\.0561031585843301\ \(0\)\
\-\ by\\:\\ 0\\.05561681082825559\ \(0\)\
\-\ rheumatology\\:\\ 0\\.05492342553760766\ \(0\)\
\-\ chondral\\:\\ 0\\.05492342553760766\ \(0\)\
\-\ clinics\\:\\ 0\\.05492342553760766\ \(0\)\
\-\ be\\:\\ 0\\.05312867496274161\ \(0\)\
\-\ symphysis\\:\\ 0\\.05300008704507954\ \(0\)\
\-\ as\\:\\ 0\\.05261468501345116\ \(0\)\
\-\ menisci\\:\\ 0\\.0525863043245072\ \(0\)\
\-\ calcify\\:\\ 0\\.0525863043245072\ \(0\)\
\-\ hemochromatosis\\:\\ 0\\.05219375078836927\ \(0\)\
\-\ chondrocalcinosis\\:\\ 0\\.05146433091860145\ \(0\)\
\-\ america\\:\\ 0\\.05146433091860145\ \(0\)\
\-\ capsular\\:\\ 0\\.05112413641963045\ \(0\)\
\-\ gastrocnemius\\:\\ 0\\.05112413641963045\ \(0\)\
\-\ compartment\\:\\ 0\\.05112413641963045\ \(0\)\
\-\ fascia\\:\\ 0\\.05079842275010993\ \(0\)\
\-\ north\\:\\ 0\\.050486007287378044\ \(0\)\
\-\ annulus\\:\\ 0\\.05018584661682636\ \(0\)\
\-\ acetabular\\:\\ 0\\.049897015505828986\ \(0\)\
\-\ labrum\\:\\ 0\\.049897015505828986\ \(0\)\
\-\ quadriceps\\:\\ 0\\.04961868970338749\ \(0\)\
\-\ deposits\\:\\ 0\\.04961868970338749\ \(0\)\
\-\ pubic\\:\\ 0\\.04935013175942738\ \(0\)\
\-\ structural\\:\\ 0\\.04909067924911871\ \(0\)\
\-\ intervertebral\\:\\ 0\\.047695351210859376\ \(0\)\
\-\ tendons\\:\\ 0\\.0470827750775758\ \(0\)\
\-\ lunate\\:\\ 0\\.0468890149541491\ \(0\)\
\-\ supraspinatus\\:\\ 0\\.04670003952364552\ \(0\)\
\-\ tears\\:\\ 0\\.04615959508438128\ \(0\)\
\-\ elderly\\:\\ 0\\.04598760770986815\ \(0\)\
\-\ wedge\\:\\ 0\\.045654811100386945\ \(0\)\
\-\ meniscal\\:\\ 0\\.04518127145315788\ \(0\)\
\-\ synovial\\:\\ 0\\.0448811107826062\ \(0\)\
\-\ triceps\\:\\ 0\\.0448811107826062\ \(0\)\
\-\ present\\:\\ 0\\.044802785918096645\ \(0\)\
\-\ affects\\:\\ 0\\.04473533273535708\ \(0\)\
\-\ plantar\\:\\ 0\\.044592279671608816\ \(0\)\
\-\ arthropathy\\:\\ 0\\.044178496951036476\ \(0\)\
\-\ gout\\:\\ 0\\.04404539592520721\ \(0\)\
\-\ bearing\\:\\ 0\\.04294143692404421\ \(0\)\
\-\ disk\\:\\ 0\\.04294143692404421\ \(0\)\
\-\ sites\\:\\ 0\\.0426062103681761\ \(0\)\
\-\ subchondral\\:\\ 0\\.041778039243355644\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.04158427911992893\ \(0\)\
\-\ isolated\\:\\ 0\\.041489208132358256\ \(0\)\
\-\ 2004\\:\\ 0\\.04112031185178555\ \(0\)\
\-\ radiologic\\:\\ 0\\.04068287187564799\ \(0\)\
\-\ ossification\\:\\ 0\\.04059830619663319\ \(0\)\
\-\ degeneration\\:\\ 0\\.04059830619663319\ \(0\)\
\-\ older\\:\\ 0\\.040514664751190116\ \(0\)\
\-\ characterized\\:\\ 0\\.04010964346956123\ \(0\)\
\-\ diseases\\:\\ 0\\.04010964346956123\ \(0\)\
\-\ frequent\\:\\ 0\\.04003114928319432\ \(0\)\
\-\ articular\\:\\ 0\\.03987653561893771\ \(0\)\
\-\ larger\\:\\ 0\\.03907785630741969\ \(0\)\
\-\ observed\\:\\ 0\\.038873761116816306\ \(0\)\
\-\ 42\\:\\ 0\\.0388069212501989\ \(0\)\
\-\ form\\:\\ 0\\.03816879211794649\ \(0\)\
\-\ much\\:\\ 0\\.037809986592757076\ \(0\)\
\-\ ligament\\:\\ 0\\.0375233195185566\ \(0\)\
\-\ degenerative\\:\\ 0\\.03708587954241904\ \(0\)\
\-\ numerous\\:\\ 0\\.03687619201245008\ \(0\)\
\-\ even\\:\\ 0\\.03672261262295433\ \(0\)\
\-\ fibrosis\\:\\ 0\\.03657205466418811\ \(0\)\
\-\ shaped\\:\\ 0\\.036473303409135474\ \(0\)\
\-\ frequently\\:\\ 0\\.03595183687666879\ \(0\)\
\-\ underlying\\:\\ 0\\.03563758855173648\ \(0\)\
\-\ suggest\\:\\ 0\\.03546364660791603\ \(0\)\
\-\ before\\:\\ 0\\.035293570362413026\ \(0\)\
\-\ calcified\\:\\ 0\\.03516844851145886\ \(0\)\
\-\ linear\\:\\ 0\\.03516844851145886\ \(0\)\
\-\ involved\\:\\ 0\\.035004739251415645\ \(0\)\
\-\ around\\:\\ 0\\.03484445871086808\ \(0\)\
\-\ foot\\:\\ 0\\.034495648747651354\ \(0\)\
\-\ currently\\:\\ 0\\.03353553237976882\ \(0\)\
\-\ an\\:\\ 0\\.03338793711705414\ \(0\)\
\-\ 13\\:\\ 0\\.03292552742611006\ \(0\)\
\-\ being\\:\\ 0\\.030421329033346534\ \(0\)\
\-\ this\\:\\ 0\\.03000208464932884\ \(0\)\
\-\ followed\\:\\ 0\\.02948047264975222\ \(0\)\
\-\ first\\:\\ 0\\.029460824073924086\ \(0\)\
\-\ space\\:\\ 0\\.029059445109845317\ \(0\)\
\-\ should\\:\\ 0\\.028485640826856878\ \(0\)\
\-\ often\\:\\ 0\\.028485640826856878\ \(0\)\
\-\ patient\\:\\ 0\\.028398313696009432\ \(0\)\
\-\ such\\:\\ 0\\.028081866343684675\ \(0\)\
\-\ primary\\:\\ 0\\.02684382800138236\ \(0\)\
\-\ demonstrated\\:\\ 0\\.026829900579738334\ \(0\)\
\-\ loss\\:\\ 0\\.026596931877944922\ \(0\)\
\-\ changes\\:\\ 0\\.026383961861937543\ \(0\)\
\-\ one\\:\\ 0\\.02499520020424513\ \(0\)\
\-\ patients\\:\\ 0\\.024558976843018526\ \(0\)\
\-\ without\\:\\ 0\\.02302698238586229\ \(0\)\
\-\ associated\\:\\ 0\\.023010069415263432\ \(0\)\
\-\ imaging\\:\\ 0\\.022942788840570615\ \(0\)\
\-\ lateral\\:\\ 0\\.021665592833736928\ \(0\)\
\-\ presents\\:\\ 0\\.021000865792816438\ \(0\)\
\-\ seen\\:\\ 0\\.020552966057463835\ \(0\)\
\-\ male\\:\\ 0\\.019437401246761497\ \(0\)\
\-\ that\\:\\ 0\\.018945135717433496\ \(0\)\
\-\ there\\:\\ 0\\.01737065007538397\ \(0\)\
\-\ pain\\:\\ 0\\.015621780199658456\ \(0\)\
\-\ to\\:\\ 0\\.01091395393013676\ \(0\)\
\-\ with\\:\\ 0\\.008548421663138671\ \(0\)\
